Artwork

Inhoud geleverd door Squirro. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Squirro of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Spotlight Six: The Integration of AI in Life Sciences and Biotechnology Sectors

1:38
 
Delen
 

Manage episode 408266731 series 3454356
Inhoud geleverd door Squirro. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Squirro of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Season Three - Spotlight Six

Our sixth spotlight of this season is a snippet from our upcoming episode:⁠ Dave Latshaw, Ph.D., MBA - The Integration of AI in Life Sciences and Biotechnology Sectors.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding BioPhy.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

Listen to the full episode, as soon as it comes out by subscribing to Redefining AI and please do share your excitement about the episode with your own network!

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

105 afleveringen

Artwork
iconDelen
 
Manage episode 408266731 series 3454356
Inhoud geleverd door Squirro. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Squirro of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Season Three - Spotlight Six

Our sixth spotlight of this season is a snippet from our upcoming episode:⁠ Dave Latshaw, Ph.D., MBA - The Integration of AI in Life Sciences and Biotechnology Sectors.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding BioPhy.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

Listen to the full episode, as soon as it comes out by subscribing to Redefining AI and please do share your excitement about the episode with your own network!

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

105 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding